Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia

标题
Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 29, Issue 12, Pages 1634-1642
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2011-03-22
DOI
10.1200/jco.2010.32.0598

向作者/读者发起求助以获取更多资源

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started